Global Healthcare Group

Houlihan Lokey’s Healthcare Group is pleased to share these recent accomplishments, highlighting the activity and breadth of its global team partially into 2024.

Houlihan Lokey’s Healthcare Group has built a reputation for providing a collaborative, team-based approach that puts its clients’ interests first and delivers superior outcomes in both M&A advisory and capital-raising assignments. In 2023, LSEG (formerly Refinitiv) ranked our team as the No. 1 M&A advisor for all global healthcare transactions* with 34 healthcare M&A deals.

For more information on the team’s services or to discuss how the firm can help advance your vision, please contact your Houlihan Lokey representative or one of the individuals listed at the end of this message.

Click on selected transactions below for more details.

*Excludes accounting firms and brokers.

Houlihan Lokey is delighted to host its 2024 Global Healthcare Conference at the InterContinental New York Barclay on October 30, 2024.

This exclusive, invite-only event is designed to unite business leaders and investors for a dynamic day focused on fostering relationships, gaining valuable insights, and sharing ideas. Attendees will delve into the market dynamics and strategies employed within a variety of healthcare sectors and participate in insightful discussions on the state of the market, growth opportunities, and current challenges.

Click here to request an invitation.

About Houlihan Lokey

Houlihan Lokey, Inc. (NYSE:HLI) is a global investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, and financial and valuation advisory. Houlihan Lokey serves corporations, institutions, and governments worldwide with offices in the Americas, Europe, the Middle East, and the Asia-Pacific region. Independent advice and intellectual rigor are hallmarks of the firm’s commitment to client success across its advisory services. The firm is the No. 1 investment bank for all global M&A transactions, the No. 1 M&A advisor for the past nine consecutive years in the U.S., the No. 1 global restructuring advisor for the past ten consecutive years, and the No. 1 global M&A fairness opinion advisor over the past 25 years, all based on number of transactions and according to data provided by LSEG (formerly Refinitiv).